Consistently, we found that S‐adenosylhomocysteine (SAH), a METTL3/METTL14 dual inhibitor, greatly suppressed miR‐99a‐5p expression in ESCC cells (Figure 3A). Here, METTL14 is linked to esophageal squamous cell carcinoma.